Study results, soon to be published, show MesenCure treatment reduced study participants' hospitalization period by about half compared to a control group. All these patients had life-threatening pneumonia and respiratory distress caused by Covid-19.

The data shows that MesenCure treatment reduced mortality by about 70% compared with the control group. Only two of the first 30 severe Covid-19 patients treated with MesenCure died due to Covid-19 or its complications, while 14 of 60 similar patients in the control group died.

MesenCure treatment shortened the hospitalization period of severe Covid-19 patients by eight days on average, a reduction of 45% relative to the control group.

The experimental group included women and men aged 41.4 to 77.4. About 77% of the severe Covid-19 patients treated in three hospitals with MesenCure had one or more risk factors for poor prognosis: hypertension, hyperlipidemia, obesity and Type 2 diabetes. Most were treated during the fourth Covid-19 wave in Israel, dominated by the Delta strain.

The control group received the current standard of care — anti-inflammatory drugs in combination with steroids. This regimen, according to Bonus BioGroup, reduces mortality in hospitalized Covid-19 patients only slightly, from 25.8% to 21.8%, indicating that MesenCure is four times more effective.

"We are proud of our success in leading the world to be a safer place by developing a medication for severe Covid-19 patients, thereby dramatically reducing the threat to their lives," said Dr. Shai Meretzki, CEO of Bonus BioGroup.

"In less than two years from the epidemic outbreak, we are the first in the world to report an effective and significant treatment for severely ill patients."

According to a statement from Bonus BioGroup, an independent expert committee confirmed the findings of the Phase II clinical trial of MesenCure and recommended continuing toward Phase III. Meretzki told the Jerusalem Post that the company will apply for emergency use approval from European and US regulatory agencies. Subscribe for free to Breaking Christian News here

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Joe Rogan: 'I'm Fascinated by the Story of Jesus Christ' [Video]

Politicians Called It a 'Chemtrail Conspiracy.' The CIA's Own Files Just Proved Them Wrong

Scotland's Parliament Votes against Assisted Suicide in Pro-Life Victory

Weird: Iraq-Born Man Released from Jail after Bringing Gun, Wearing Tactical Gear, to Texas Elementary School

Iran's Islamic Regime Shows That It Is Truly Evil and Must Be Stopped

Amid War and Persecution, Iran's Christian Community Quietly Grows

Joe Kent Resigns as NCTC Director Citing Opposition to War; Then Trump Posts This Screenshot of Kent's Old Tweet

Senate Opens Debate on SAVE America Act

'Mercy Triumphs Over Judgment': Charges Dropped Against Teen Who Tragically Ran Over Teacher

Ecuador's Daniel Noboa Cracks Down on Crime, and We're All Better Off For It

More Than 300 Iranians Apprehended by Border Patrol Under Trump; Center Square Exclusive

Thousands of Texans Call on Congress to Stop Big Bend Border Wall Construction

Therapist Exposes the 'Pathological' Mentality Behind the Transgender Mutilation Pipeline

Mamdani Appoints 'Transgender' Attorney to Lead New York City's New Office of LGBT Affairs

President Trump Formally Names VP Vance Chair of Fraud Task Force; With California, New York among States in the Crosshairs

2 Iranian Women's Soccer Players Who Defected, Ditch Their Hijabs, Practice with Australian Club after Being Granted Asylum

Over 1,000 Expected at Today's 6th Annual California March for Life

Most Voters Support Bans on Transgender Athletes in Female Sports

Monthly Personal Savings Rate in January Highest Since July, Helped by Lower Taxes

US Senate to Hold Marathon Debate on GOP Voter ID Bill